The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study
Journal of Antimicrobial Chemotherapy2024Vol. 79(8), pp. 1831–1842
Citations Over TimeTop 17% of 2024 papers
Edward Webb, Daniel Howdon, Rebecca Bestwick, Natalie King, Jonathan Sandoe, Joanne Euden, Detelina Grozeva, Robert West, Philip Howard, Neil Powell, Mahableshwar Albur, Stuart Bond, Lucy Brookes‐Howell, Paul Dark, Thomas P Hellyer, Martin Llewelyn, Iain McCullagh, Margaret Ogden, Philip Pallmann, Helena Parsons, David G. Partridge, Dominick Shaw, Tamás Szakmány, Stacy Todd, Emma Thomas‐Jones, Enitan D. Carrol, Bethany Shinkins, PEACH Study Group, Jonathan Sandoe, Enitan D. Carrol, Emma Thomas‐Jones, Lucy Brookes‐Howell, Josie Henley, Wakunyambo Maboshe, Philip Pallmann, Detelina Grozeva, Marcin Bargiel, Judith F. Evans, Edward Webb, Rebecca Bestwick, Daniel Howdon, Robert West, Colin Richman, Sarah Gerver, Russell Hope, Susan Hopkins, Margaret Heginbothom, Philip Howard, Jonathan Sandoe, C.A. Berry, Georgina Davis, Vikki Wilkinson, Stacy Todd, Eleanor Taylor-Barr, Mary Brodsky, Jo Brown, Jenni Burns, Sharon Glynn, Alvyda Gureviciute, Megan W. Howard, Jennifer Kirkpatrick, Hannah Murphy, Emma Richardson, Deborah Scanlon, Claire Small, Grant Sweeny, Lisa Williams, Tamás Szakmány, Evelyn Baker, Yusuf Cheema, Jill Dunhill, Charlotte Killick, Charlie King, Simran Kooner, Swyn Lewis, Maxine Nash, O. N. Richardson, J Tuffney, C. I. Westacott, Sarah E. Williams, David G. Partridge, Helena Parsons, Kay Cawthron, Yuen Kiu Tai, Thomas H. Newman, Megan Plowright, Helen Shulver, Anna Sivakova, Neil Powell, Freddie Ayliffe, Emma Darke, Eve Fletcher, Fiona Hammonds, Gladys Márquez, Leanne Welch, Stuart Bond, Jade Lee-Milner, J. L. Spencer, Mahableshwar Albur, Rodrigo Borges Brandão, J Hrycaiczuk, Jack Stanley, Martin Llewelyn, Elizabeth Cross, Daniel Hansen, Ethan Redmore, Abigail Whyte, Thomas P Hellyer, Iain McCullagh, Benjamin Brown, Michele Calabrese, Cameron H Cole, Jessica DeSousa, Leigh Dunn, Stephanie Grieveson, Arti Gulati, Elizabeth P Issac, Ruaridh Mackay, Fatima Simoes, Paul Dark, Elena Apatri, Bethan Charles, Helen Christensen, Alice Harvey, Diane Lomas, Melanie Taylor, Vicky Thomas, Danielle Walker, Dominick Shaw, Lucy Howard, Amelia Joseph, Saheer Sultan, Chikezie Knox-Macaulay, Margaret Ogden, Graham Prestwich, Ryan Hamilton
Abstract
Using PCT to guide antibiotic therapy in individuals hospitalized with COVID-19 is more likely to be cost-effective than not, albeit with uncertainty.
Related Papers
- → Rotator cuff repair: An analysis of utility scores and cost-effectiveness(2007)255 cited
- → Cost-Effectiveness Analysis of Augmentation Therapy for Severe α1-Antitrypsin Deficiency(2003)73 cited
- → Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS)(2022)22 cited
- → Cost-Effectiveness of Computer-Tailored Smoking Cessation Advice in Primary Care: A Randomized Trial (ESCAPE)(2013)20 cited
- → Preference-based comparative effectiveness and cost–effectiveness(2012)15 cited